Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: A randomized, clinical trial

Human Reproduction

Volumn 24, Issue 2, 2009, Pages 349-359

  Fábregues, Francisco ^a   Peñarrubia, Joana ^a   Creus, Montserrat ^a   Manau, Dolors ^a   Casals, Gemma ^a   Carmona, Francisco ^a   Balasch, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Androgens; IVF; Low responders; Ovarian stimulation

Indexed keywords

FOLLITROPIN; GONADORELIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS FUNCTION; INFERTILITY; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARY FUNCTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

MACACA;

EID: 58449090422     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den428     Document Type: Article

References (43)

1. Balasch J, Fábregues F, Peñarrubia J, Carmona F, Casamitjana R, Creus M, Manau D, Casals G, Vanrell JA. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Hum Reprod 2006;21:1884-1893.
2. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-336.
3. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006;21:2845-2849.
4. Billig H, Furuta I, Hsueh JW. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 1993;133:2204- 2212.
5. Buckler HM, Robertson WR, Wu FCW. Which androgen replacement therapy for women? J Clin Endocrinol Metab 1998;83:3920-3924.
6. Creus M, Peñarrubia J, Fábregues F, Vidal E, Carmona F, Casamitjana R, Vanrell JA, Balasch J. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 2000;15:2341-2346.
7. Davis OK, Rosenwaks Z. In vitro fertilization. In: Adashi EY, Rock JA, Rosenwaks Z (eds). Reproductive Endocrinology, Surgery, and Technology, Vol. 2. Philadelphia: Lippincott-Raven, 1996, 2319-2334.
8. De Placido G, Alviggi C, Mollo A, Strina I, Varricchio MT, Molis M. Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone. Hum Reprod 2000;15:17-20.
9. De Sanctis V, Vullo C, Urso L, Rigolin, Cavallini A, Caramelli K, Daugherty C, Mazer N. Clinical experience using the Androderm® testosterone transdermal system in hypogondal adolescents and young men with β-thalassemia major. J Pediatric Endocrinol Metab 1998;11:891-900.
10. Durnerin CI, Erb K, Fleming R, Hillier H, Hillier SG, Howles CM, Hugues JN, Lass A, Lyall H, Rasmussen P et al., Luveris Pretreatment Group. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum Reprod 2008;23:421-426.
11. El Toukhy T, Khalaf Y, Hart R, Taylor A, Braude P. Young age does not protect against the adverse effects of reduced ovarian reserve - an eight year study. Hum Reprod 2002;17:1519-1524.
12. Garcia-Velasco JA, Isaza V, Requena A, Martinez-Salazar FJ, Landazábal A, Remohí J, Pellicer A, Simón C. High dose of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod 2000;15:2292-2296.
13. Hanoch J, Lavy Y, Holzer H, Hurwitz A, Simon A, Revel A, Laufer N. Young low responders protected from untoward effects of reduced ovarian response. Fertil Steril 1998;69:1001-1004.
14. Hillier SG, Tetsuka M. Role of androgens in follicle maturation and atresia. Baillièrés Clin Obstet Gynaecol 1997;11:249-260.
15. Hillier SG, Whitelaw PF, Smyth CD. Follicular estrogen synthesis: the 'the two-cell, two-gonadotrophiń model revisited. Mol Cell Endocrinol 1994;100:51-54.
16. Hillier SG, Tetsuka M, Fraser HM. Location and developmental regulation of androgen receptor in the primate ovary. Hum Reprod 1997;12:107-111.
17. Hompes PGA, Broekmans FJ, Hoozemans DA, Schats R, for the FIRM group. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization- intracytoplasmic sperm injection patients. Fertil Steril 2008;89:1685-1693.
18. Hugues JN. Impact of androgen on fertility - physiological, clinical and therapeutical aspects. Reprod Biomed Online 2005;11:570-580.
19. Hugues JN, Cedrin Durnerin I. Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins. Hum Reprod Update 1998;4:83-101.
20. Kaipia A, Hsueh AJW. Regulation of ovarian follicle atresia. Annu Rev Physiol 1997;59:349-363.
21. Klinkert ER, Broekmans FJM, Looman CWN, te Velde ER. A poor response in the first in vitro fertilization cycles is not necessarily related to a poor prognosis in subsequent cycles. Fertil Steril 2004;81:1247- 1253.
22. Klinkert ER, Broekmans FJM, Looman CWN, Habbema JDF, te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF: a randomized controlled trial. Hum Reprod 2005;20:611-615.
23. Laml T, Obruca A, Fischl F, Huber JC. Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women. Gynecol Endocrinol 1999;13:98-103.
24. Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe G, Picconeri MG, Campbell A, Rowe P. Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reprod BioMed Online 2001;3:190-194.
25. Lossl K, Yding Andersen C, Loft A, Freiesleben NL, Bangsbøll S, Nyboe Andersen A. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Hum Reprod 2008;23:1820-1829.
26. Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP, Hugues JN. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique - a prospective, randomized, double-blind study. Hum Reprod 2006;21:1204-1211.
27. Mazer NA. New clinical applications of transdermal testosterone delivery in men and women. J Control Release 2000;65:303-315.
28. Meo F, Rainieri DM, Khadum I, Serhal P. Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin. Fertil Steril 2002;77:630-632.
29. Pache TD, Wladimiroff JW, de Jong FH, Hop WC, Fauser BC. Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril 1990;54:638-642.
30. Peñarrubia J, Fábregues F, Manau D, Creus M, Carmona F, Casamitjana R, Vanrell JA, Balasch J. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. Hum Reprod 2005;20:622-628.
31. 1 phase. Endocrinology 2002;143:2930-2935.
32. Raga F, Bonilla-Musoles F, Casañ EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod 1999;14:1431-1434.
33. Scheffer GJ, Broekmans FJM, Dorland M, Habbema JDF, Looman CWN, te Velde ER. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999;72:845- 851.
34. Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419-424.
35. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76.
36. The Practice Committee of the American Society for Reproductive Medicine. Aging and infertility in women. Fertil Steril 2006;86(Suppl. 4):S248-S252.
37. Veeck LL. An Atlas of Human Gametes and Conceptuses: An Illustrated Reference for Assisted Reproductive Technology. New York: CRC Press-Parthenon Publishers, 1999.
38. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-2629.
39. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M, Bondy CA. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 1999;61:353-357.
40. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, Bondy CA. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 1998;83:2479-2485.
41. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-2956.
42. Zeleznik AJ, Hillier SG, Ross GT. Follicle stimulating hormone-induced follicular development: an examination of the role of androgens. Biol Reprod 1979;21:673-681.
43. Zeleznik AJ, Littler-Ihrig L, Ramasawamy S. Administration of dihydrotestosterone to rhesus monkeys inhibits gonadotropin-stimulated ovarian steroidogenesis. J Clin Endocrinol Metab 2004;89:860-866.